AbbVie Inc.

NORTH CHICAGO, IL How do I update this listing?

Create Email Alert

Abbvie is based out of North Chicago. AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. AbbVie products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, human immunodeficiency virus (HIV), cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease and complications associated with chronic kidney disease, among other indications. AbbVie is a wholly owned subsidiary of Abbott Laboratories (Abbott). AbbVie's portfolio of products includes a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products, virology products, endocrinology products, dyslipidemia products and other products. In October 2012, AbbVie initiated a comprehensive Phase III program for hepatitis C virus (HCV) genotype one.Whalewisdom has at least 1 13D filings, 5 13G filings, and 234 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2016-05-09. The notice included securities offered of Equity

Contact Info

abbvie inc.
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO IL    60064

Business Phone: (847) 932-7900
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2016-05-09 D PHARMACEUTICALS Equity 3,800,000,000 3,800,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
AZITA SALEKI-GERHARDT subscription required
    EXECUTIVE OFFICER
BRETT J. HART subscription required
    DIRECTOR
CARLOS ALBAN subscription required
    EXECUTIVE OFFICER
EDWARD M. LIDDY subscription required
    DIRECTOR
EDWARD J. RAPP subscription required
    DIRECTOR
FREDERICK H. WADDELL subscription required
    DIRECTOR
GLENN F. TILTON subscription required
    DIRECTOR
HENRY GOSEBRUCH subscription required
    EXECUTIVE OFFICER
LAURA J. SCHUMACHER subscription required
    EXECUTIVE OFFICER
MICHAEL E. SEVERINO subscription required
    EXECUTIVE OFFICER
RICHARD A. GONZALEZ subscription required
    EXECUTIVE OFFICER DIRECTOR
ROBERT J. ALPERN subscription required
    DIRECTOR
ROXANNE S. AUSTIN subscription required
    DIRECTOR
THOMAS A. HURWICH subscription required
    EXECUTIVE OFFICER
TIMOTHY J. RICHMOND subscription required
    EXECUTIVE OFFICER
WILLIAM H.L. BURNSIDE subscription required
    DIRECTOR
WILLIAM J. CHASE subscription required
    EXECUTIVE OFFICER

Elevate your investments